Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Market Game-Changer?

5 days ago 4
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 study titled ‘A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLAC...
Read Entire Article